Development of safe and efficient novel nonviral gene transfer using ultrasound: Enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle

Gene Therapy

Volumn 9, Issue 6, 2002, Pages 372-380

  Taniyama, Y ^a   Tachibana, K ^a   Hiraoka, K ^a   Aoki, M ^a   Yamamoto, S ^a   Matsumoto, K ^a   Nakamura, T ^a   Ogihara, T ^a   Kaneda, Y ^a   Morishita, R ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Angiogenesis; Gene therapy; HGF; Peripheral arterial disease; Ultrasound

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; GLYCERYL TRINITRATE; GROWTH FACTOR; LUCIFERASE; NAKED DNA; PAPAVERINE; PLASMID DNA; SCATTER FACTOR; VIRUS VECTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DISEASE; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE MEASUREMENT; CAPILLARY DENSITY; CELL MEMBRANE PERMEABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG SAFETY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIMB ISCHEMIA; MALE; MUSCLE CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; RABBIT; RAT; SKELETAL MUSCLE; TRANSGENE; ULTRASOUND; ULTRASOUND THERAPY;

ADENOVIRIDAE; ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0036227368     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301678     Document Type: Article

References (43)

1. Second European Consensus Document on Chronic Critical Leg Ischemia
2. Fate of the patient with chronic leg ischaemia. A review article
3. Suggested standards for reports dealing with lower extremity ischemia
4. Clinical evidence of angiogenesis after arterial gene transfer of ph VEGF165 in patient with ischaemic limb
5. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
6. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results
7. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor
8. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
9. Left ventricular electromechanical mapping to assess efficacy of phVEGF165 gene transfer for therapeutic angiogenesis in chronic myocardial ischemia
10. Angiogenesis gene therapy: Phase 1 assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
11. Six-month assessment of a phase 1 trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA
12. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hind limb ischemia models: Preclinical study for treatment of peripheral arterial disease
13. Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: Critical role of secretion signal in use of naked DNA
14. Adenovirus-mediated expression of the secreted form of basic fibroblast growth factor (FGF-2) induces cellular proliferation and angiogenesis in vivo
15. Adenovirus-mediated gene transfer of basic fibroblast growth factor induces in vitro angiogenesis
16. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor
17. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart
18. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: Upregulation of essential transcription factor for angiogenesis, ets
19. Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart
20. Adenovirus-mediated acidic fibroblast growth factor gene transfer induces angiogenesis in the nonischemic rabbit heart
21. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat - Angiogenesis and angioma formation
22. Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: Effect on myocardial angiogenesis
23. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121
24. Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia
25. Percutaneous adenoviral gene transfer into porcine coronary arteries: Is catheter-based gene delivery adapted to coronary circulation?
26. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus
27. Fusigenic viral liposome for gene therapy in cardiovascular diseases
28. Gene therapy death prompts review of adenovirus vector
29. Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and β-galactosidase gene in non-infarcted area, but not myocardial infarcted area
30. Critical leg ischaemia: An appraisal of clinical definitions
31. Amputation for occlusive arterial disease. A prospective multicentre study of 177 amputees
32. Late outcomes of limb loss after failed infrainguinal bypass
33. Use of the rabbit ear artery to serially assess foreign protein secretion after site specific arterial gene transfer in vivo: Evidence that anatomic identification of successful gene transfer may underestimate the of transgene expression
34. In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound
35. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection
36. Ultrasound facilitates transduction of naked plasmid DNA into colon carcinoma cells in vitro and in vivo
37. Induction of cell-membrane porosity by ultrasound
38. Microbubble-enhanced ultrasound for vascular gene delivery
39. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis
40. Physical and biochemical stability of Optison, an injectable ultrasound contrast agent
41. Efficient in vivo gene transfer into heart in rat myocardial infarction model using HVJ (hemagglutinating virus of Japan)-liposome method
42. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as 'cytokine supplement therapy'
43. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: Down-regulation of HGF in response to hypoxia in vascular cells